The Patent Finder

Arriva Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Arriva Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Arriva Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 7,914,771Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
Lapsed on the fee record
Ended Mar 29, 2019 · From the USPTO record
Lapsed on the fee recordEnded Mar 29, 2019From the USPTO record
US 7,892,825Method of protein production in yeast
Lapsed on the fee record
Ended Feb 22, 2019 · From the USPTO record
Lapsed on the fee recordEnded Feb 22, 2019From the USPTO record
US 7,709,446Multifunctional protease inhibitors and their use in treatment of disease
Lapsed on the fee record
Ended May 4, 2014 · From the USPTO record
Lapsed on the fee recordEnded May 4, 2014From the USPTO record
US 7,419,801Methods of protein production in yeast
Lapsed on the fee record
Ended Sep 2, 2012 · From the USPTO record
Lapsed on the fee recordEnded Sep 2, 2012From the USPTO record
US 7,247,704Multifunctional protease inhibitors and their use in treatment of disease
Lapsed on the fee record
Ended Jul 24, 2011 · From the USPTO record
Lapsed on the fee recordEnded Jul 24, 2011From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited